Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00445367 · ClinicalTrials.gov registry record

Biobank For MS And Other Demyelinating Diseases

A clinical trial of Multiple Sclerosis and Neuromyelitis Optica, sponsored by Accelerated Cure Project for Multiple Sclerosis.

Active
Registry status
3,226
Enrollment target
10
Study locations

NCT00445367 is a study of Multiple Sclerosis and Neuromyelitis Optica that is active but no longer recruiting, run by Accelerated Cure Project for Multiple Sclerosis. The registered enrollment target is 3,226 participants, above the 575-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (461% higher). The trial reports 10 study locations across 9 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00445367, a study of Multiple Sclerosis and Neuromyelitis Optica, is active but no longer recruiting, sponsored by Accelerated Cure Project for Multiple Sclerosis.

ACTIVE NOT RECRUITING
Registry status
3,226 participants
Enrollment target
10
Study locations

Study Summary

To establish a large, longitudinal collection of high quality samples and data from subjects with MS, selected other demyelinating diseases (Transverse Myelitis (TM), Neuromyelitis Optica (NMO) or Devic's, Acute Disseminated Encephalomyelitis (ADEM), and Optic Neuritis (ON)), and related and unrelated unaffected controls. Samples and data will be available as a shared resource to scientists researching the causes, sub-types, and biomarkers of MS and related demyelinating diseases.

Conditions Studied

Multiple Sclerosis Neuromyelitis Optica Optic Neuritis Transverse Myelitis Acute Disseminated Encephalomyelitis

Study Locations (10)

Massachusetts

  • Beth Israel Deaconess - Boston
  • University of Massachusetts Medical School - Worcester

Arizona

  • Barrow Neurological Institute - Phoenix

California

  • Stanford University - Stanford

Colorado

  • The Rocky Mountain MS Center at Anschutz Medical Campus at UC Denver - Aurora

Georgia

  • Shepherd Center - Atlanta

Maryland

  • Johns Hopkins - Baltimore

New York

  • Multiple Sclerosis Research Center of New York - New York

Ohio

  • The Ohio State University - Columbus

Trial Details

FieldValue
Enrollment Target 3,226 participants
Start Date 2006-05
Est. Completion 2036-10

Sponsor

Accelerated Cure Project for Multiple Sclerosis

3 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00445367

The ClinicalTrials.gov registry entry for NCT00445367 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 3,226 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 575-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (461% higher). The listed sponsor is Accelerated Cure Project for Multiple Sclerosis, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Multiple Sclerosis appearing as the primary indexed condition, and to 0 interventions.

NCT00445367 reports 10 study locations spanning 9 distinct geographic areas - top geographies include Massachusetts, Arizona, California.

Frequently Asked Questions

What is clinical trial NCT00445367 about?

NCT00445367 is a clinical study titled "Biobank For MS And Other Demyelinating Diseases". To establish a large, longitudinal collection of high quality samples and data from subjects with MS, selected other demyelinating diseases (Transverse Myelitis (TM), Neuromyelitis Optica (NMO) or Devic's, Acute Disseminated Encephalomyelitis (ADEM), and Optic Neuritis (ON)), and related and unrelat...

What is the current status of trial NCT00445367?

This trial is currently active not recruiting. The enrollment target is 3,226 participants. The study started on 2006-05. Estimated completion is 2036-10.

What conditions does trial NCT00445367 study?

This clinical trial studies the following conditions: Multiple Sclerosis, Neuromyelitis Optica, Optic Neuritis, Transverse Myelitis, Acute Disseminated Encephalomyelitis.

Who is sponsoring clinical trial NCT00445367?

This trial is sponsored by Accelerated Cure Project for Multiple Sclerosis, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00445367 being conducted?

This trial has 10 study locations across Arizona, California, Colorado, Georgia, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Multiple Sclerosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Multiple Sclerosis

All registered trials for this condition

Neuromyelitis Optica

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.